Safe and Readily Authenticated Pharmaceutical dosage forms tablets
The occurrence of cross-border illicit trade and seizures of counterfeit goods by EU-authorities continues to rise year on year. The OECD and the EU’s Intellectual Property Office (EUIPO) estimate that imports of counterfeit and p...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
CONPHIRMER
Counterfeit Pharmaceuticals Interception using Radiofrequenc...
4M€
Cerrado
RTC-2017-6253-1
SABERMED: Swarm Agent-Based Environment For Reputation in ME...
584K€
Cerrado
SAFESCIMET
European Modular Education and Training Programme in Safety...
6M€
Cerrado
PEARRL
Pharmaceutical Education And Research with Regulatory Links...
4M€
Cerrado
SAFESCIMET
European Modular Education and Training Programme in Safety...
6M€
Cerrado
Información proyecto SRAP
Duración del proyecto: 6 meses
Fecha Inicio: 2018-03-05
Fecha Fin: 2018-09-30
Líder del proyecto
NANO4U AG
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The occurrence of cross-border illicit trade and seizures of counterfeit goods by EU-authorities continues to rise year on year. The OECD and the EU’s Intellectual Property Office (EUIPO) estimate that imports of counterfeit and pirated goods are worth nearly half a trillion dollars a year, or around 2.5% of global imports, with US, Italian and French brands the hardest hit. In the EU, the Falsified Medicines Directive (FMD) requires the introduction of a full tracking and tracing system by February 2019. Medicine packs will need to contain a unique identifier (2D barcode) and an anti-tampering device (such as labels), i.e. a technical means to ensure that the content of the package has not been tampered with. At present, there is no technology available on the global market which allows a true authentication of pharmaceutical products themselves, all initiatives so far concentrate on packaging only. SRAP technology overcomes this gap. SRAP is compatible with future FMD regulations; and can provide for fast, reliable and full tracking-and-tracing along the supply chain without the need to destroy product during authentication, while enabling true authentication on the product level - not just the package; and if necessary SRAP solutions provide for a database-independent authentication in the field (via mobile phone) – a very strong set of functionalities that combine to an extremely strong USP. The objectives of feasibility study are as follows – identify 3 potential commercial partners from pharmaceutical industry, define full-scale terms of reference jointly with the 3 partners identified and prepare a full business plan for a new joint venture entity.